Cologuard Included in Star Ratings
The Centers for Medicare and Medicaid Services (CMS) is including Exact Sciences’ Cologuard in the 2018 Medicare Advantage Star Ratings program, the company announced recently. “We are pleased that Cologuard has…
Category Archives: Biotech
Cellectar to Begin Phase II Trial
Cellectar Biosciences announced today its initiation of a Phase II clinical study of CLR 131 in patients with multiple myeloma and other hemotologic malignancies. According to a release, the study…
MVI Expands Clinical Trial
Madison Vaccines Incorporated’s clinical trial for metastatic prostate cancer is expanding to the University of Washington, its third site, the company announced recently. According to a release, MVI-118 is being explored for…
Cellectar Earns Japanese Patent
Cellectar Biosciences announced today the Japanese Patent Office has granted a composition of matter patent for its optical imaging phospholipid drug conjugates (PDCs), CLR 1501 and CLR 1502. “This patent…
Cellectar, WARF Reach License Agreement
Cellectar Biosciences and the Wisconsin Alumni Research Foundation announced it new license agreement for intellectual property rights covering the method of use for the company’s compound, CLR 131, in multiple…
Exact Sciences Study Shows Promise
A study by Exact Sciences and Mayo Clinic shows promise of a new blood-based lung cancer test, the organizations announced recently. “These results reveal an opportunity to detect lung cancer from…
Invenra to Collaborate with QIMR
Invenra has teamed up with Australian biomedical research and development center QIMR Berghofer Medical Research Institute to identify and characterize a panel of fully human therapeutic monoclonal antibodies against a novel…
SHINE Adds Board Member
SHINE Medical Technologies added Gregory OD Smith to its board of directors, the company announced recently. Smith has experience in the nuclear industry, having worked at Urenco, Louisiana Energy Services…
NeuroPointDX, Ovid Therapeutics Collaborate
NeuroPointDX, the diagnostics division of Stemina Biomarker Discovery, and New York-based Ovid Therapeutics announced today they will team up to identify novel biomarkers of a rare genetic disorder called Angelman syndrome….
Propeller Teams With Novartis
Propeller Health announced today it has partnered with Novartis Pharma AG to develop a custom add-on sensor for the Breezhaler inhaler to further improve adherence and care management for people living with COPD…
